Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The document is a detailed medical reference on skin and genetic disorders.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Some alopecia treatments might help treat COVID-19, but more research is needed.

White hairs often regrow in alopecia areata patches.

Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.

Azathioprine may help treat severe alopecia areata, but more research is needed.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

An elderly Chinese man lost all his hair after taking a new heart medication.

Early diagnosis and personalized treatments are crucial for better hair loss management.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

OCT can effectively screen and diagnose various medical conditions non-invasively.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

A woman's complete hair loss condition improved after recovering from COVID-19.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.